Skip to main content
Log in

Patient-Based Assessment in Dyspepsia:

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

This paper describes the development and testing of a new self-report measure, the Dyspepsia Symptom Severity Index (DSSI), for assessing the severity of symptoms commonly associated with dyspepsia. The instrument was based on the literature, focus groups, and feedback from gastroenterologists; 48 patients and 24 controls participated in testing. Patients completed the DSSI and a symptom diary to test concurrent validity; one-week reproducibility was evaluated in 21 stable patients. Three subscales comprise the 20-item DSSI, representing reflux-, ulcer-, and dysmotility-like symptoms. Subscale internal consistency levels (α) were high (0.84–0.89), total score α levels were very good (0.76, 0.80), and scores were reproducible (ICC = 0.90–0.92). Correlations between the DSSI and diary were moderate to strong (r = 0.33–0.77; P < 0.05). Patients reported significantly more severe symptoms than controls (P < 0.001). Results indicate the DSSI is a reliable and valid tool for evaluating symptom severity in patients with functional dyspepsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterology Int 4:145–160, 1991

    Google Scholar 

  2. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd: Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 102:1259–1268, 1992

    PubMed  Google Scholar 

  3. Heading RC: Definitions of dyspepsia. Scand J Gastroenterol 26(suppl 182):1–6, 1991

    Google Scholar 

  4. Colin-Jones DG: Management of dyspepsia: Report of a working party. Lancet 1(8585):576–579, 1988

    PubMed  Google Scholar 

  5. Chiba N: Definitions of dyspepsia: Time for a reappraisal. Eur J Surg Suppl 583:14–23, 1998

    Google Scholar 

  6. Grainger SL, Klass HJ, Rake MO, Williams JG: Prevalence of dyspepsia: The epidemiology of overlapping symptoms. Postgrad Med J 70:154–161, 1994

    PubMed  Google Scholar 

  7. Jebbink HJ, Smout AJ, van Berge Henegouwen GP: Ranitidine therapeutically effective in functional dyspepsia with re-flux-like symptoms. Ned Tijdschr Geneeskd 137(35):1772–1775, 1993

    PubMed  Google Scholar 

  8. Buckley MJ, Scanlon C, McGurgan P, O'Morain CA: A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol 29:495–500, 1997

    PubMed  Google Scholar 

  9. Knill-Jones RP: Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 26(suppl 182):17–24, 1991

    Google Scholar 

  10. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, Marengo M, Corinaldesi R: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 110:1036–1042, 1996

    PubMed  Google Scholar 

  11. Agreus L, Talley N: Dyspepsia: Current understanding and management. Annu Rev Med 49:475–493, 1998

    PubMed  Google Scholar 

  12. Holtmann G, Stanghellini V, Talley NJ: Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: Clarifying the concepts. Baillieres Clin Gastroenterol 12(3):417–433, 1998

    PubMed  Google Scholar 

  13. Agreus L: The epidemiology of functional gastrointestinal disorders. Eur J Surg Suppl 583:60–66, 1998

    Google Scholar 

  14. Cutts TF, Abell TL, Karas JG, Kuns J: Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia. Dig Dis Sci 41:1369–1378, 1996

    PubMed  Google Scholar 

  15. Veldhuyzen van Zanten SJ, Tytgat MAJ, Pollak PT, Goldie J, Goodacre RL, Riddell RH, Hunt RH: Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter-pylori associated gastritis? J Clin Epidemiol 46:273–279, 1993

    PubMed  Google Scholar 

  16. Veldhuyzen van Zanten SJ, Tytgat KM, Jalali S, Goodacre RL, Hunt RH: Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and campylobacter-associated gastritis. J Clin Gastroenterol 11:496–501, 1989

    PubMed  Google Scholar 

  17. Adang RP, Ambergen AW, Talmon JL, Hasman A, Vismans JF, Stockbrugger RW: The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: A study on the clinical presentation of 1,147 patients. Digestion 57(2):118–134, 1996

    PubMed  Google Scholar 

  18. Penston J, Pounder R: A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 10:83–89, 1996

    PubMed  Google Scholar 

  19. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Gastrointestinal tract symptoms and self-reported abuse: A population-based study. Gastroenterology 107(4):1040–1049, 1994

    PubMed  Google Scholar 

  20. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd: Assessment of functional gastrointestinal disease: The bowel disease questionnaire. Mayo Clin Proc 65:1456–1479, 1990

    PubMed  Google Scholar 

  21. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR: A patient questionnaire to identify bowel disease. Ann Intern Med 111:671–674, 1989

    PubMed  Google Scholar 

  22. Talley NJ, Shuter B, McCrudden G, Jones M, Hoschl R, Piper DW: Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. J Clin Gastroenterol 11(6):625–630, 1989

    PubMed  Google Scholar 

  23. Cook KF, Rabeneck L, Campbell CJM, Wray NP: Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial. J Clin Epidemiol; 52(5):381–392, 1999

    PubMed  Google Scholar 

  24. El-Omar EM, Banerjee S, Wirz A, McColl KE: The Glasgow Dyspepsia Severity Score—a tool for the global measurement of dyspepsia. Euro J Gastroenterol Hepatol 8:967–971, 1996

    Google Scholar 

  25. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard M-A, Colin R, Schoenfeld P: Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg 164(suppl 583):41–49, 1998

    Google Scholar 

  26. Haug TT, Wilhelmsen I, Ursin H, Berstad A: What are the real problems for patients with functional dyspepsia? Scand J Gastroenterol 30:97–100, 1995

    PubMed  Google Scholar 

  27. Schubert TT, Schubert AB, Ma CK: Symptoms, gastritis, and Helicobacter pylori in patients referred for endoscopy. Gastrointest Endosc 38(3):357–360, 1992

    PubMed  Google Scholar 

  28. Nagler J, Miskovitz P: Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress. Am J Gastroenterol 76(6):495–499, 1981

    PubMed  Google Scholar 

  29. Marzio L, DiFelice F, Laico MG, Imbimbo B, Lapenna D, Cuccurullo F: Gallbladder hypokinesia and normal gastric emptying of liquids in patients with dyspeptic symptoms. A double-blind placebo-controlled clinical trial with cisapride. Dig Dis Sci 37(2):262–267, 1992

    PubMed  Google Scholar 

  30. van Wijk HJ, Smout AJ, Akkermans LM, Roelofs JM, ten Thije OJ: Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol 27(2):99–102, 1992

    PubMed  Google Scholar 

  31. Czinn SJ, Bertram TA, Murray PD, Yang P: Relationship between gastric inflammatory response and symptoms in patients infected with Helicobacter pylori. Scand J Gastroenterol Suppl 181:33–37, 1991

    Google Scholar 

  32. Rosch W: Efficacy of cisapride in the treatment of epigastric pain and concomitant symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 24(suppl 165):54–58, 1989

    Google Scholar 

  33. Shah S, Dalal N: Clinical evaluation of domperidone in gastric motility disorders (R 33 812). Curr Med Prac 32(1):9–12, 1988

    Google Scholar 

  34. Testoni PA, Bagnolo F, Fanti L, Passaretti S, Tittobello A: Long-term oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients. Gut 31:288–290, 1990

    PubMed  Google Scholar 

  35. Hendrix R, Van Lint J: Experience with cisapride in the treatment of chronic functional dyspepsia. Prog Med 43(suppl 1):69–75, 1987

    Google Scholar 

  36. Verhaegen H, DeCree J, Leempoels J: Treatment of chronic dyspepsia with cisapride and domperidone. Acta Ther 13:385–394, 1987

    Google Scholar 

  37. Talley NJ, Weaver AL, Zinsmeister AR: Impact of functional dyspepsia on quality of life. Dig Dis Sci 40(3):584–589, 1995

    PubMed  Google Scholar 

  38. Abell TL, Cutts TF, Cooper T: Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life. Scand J Gastroenterol Suppl 195:60–63, discussion 63–64, 1993

    Google Scholar 

  39. Corinaldesi R, Stanghellini V, Raiti C, Rea E, Salgemini R, Barbara L: Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 28(3):300–305, 1987

    PubMed  Google Scholar 

  40. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M: Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. Arch Intern Med 158:1427–1433, 1998

    PubMed  Google Scholar 

  41. Verdu E, Fraser R, Tiberio D, Herranz M, Sipponen P, Blum L, Michetti P: Prevalence of Helicobacter pylori infection and chronic dyspeptic symptoms among immigrants from developing countries and people born in industrialized countries. Digestion 57:180–185, 1996

    PubMed  Google Scholar 

  42. Davis RH, Clench MH, Mathias JR: Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: A double-blind, placebo-controlled study. Dig Dis Sci 33(12):1505–1511, 1988

    PubMed  Google Scholar 

  43. Small PK, Loudon MA, Waldron B, Smith D, Campbell FC: Importance of reflux symptoms in functional dyspepsia. Gut 36(2):189–192, 1995

    PubMed  Google Scholar 

  44. Kuykendall DH, Rabeneck L, Campbell CJM, Wray NP: Dyspepsia: How should we measure it? J Clin Epidemiol 51(2):99–106, 1998

    PubMed  Google Scholar 

  45. Garratt AM, Ruta DA, Russell I, Macleod K, Brunt P, Mc-Kinlay A, Mowat A, Sinclair T: Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol 49(5):565–571, 1996

    PubMed  Google Scholar 

  46. Koch KL, Bingaman S: Gastric electrical activity, gastric emptying, and the water load test in evaluating patients with functional dyspepsia. Am J Gastroenterol 3:1642, 1998 (Abstract)

    Google Scholar 

  47. Nunnally JC, Bernstein IH: Psychometric Theory. 3rd ed. New York, McGraw-Hill, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leidy, N.K., Farup, C., Rentz, A.M. et al. Patient-Based Assessment in Dyspepsia:. Dig Dis Sci 45, 1172–1179 (2000). https://doi.org/10.1023/A:1005558204440

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005558204440

Navigation